Skip to main content
. 2016 Apr 25;5(7):1416–1424. doi: 10.1002/cam4.713

Figure 2.

Figure 2

(A) Sunitinib plasma concentration‐time profile; (o) represents observed concentrations and best fit line from the average parameter estimates of five patients on Cycle 1 Day 1. (B) SU012662 plasma concentration‐time profile; (o) represents observed concentrations and the line represents the average parameter estimates of 5 patients on Cycle 1 Day 1.